Currently Viewing:
Newsroom
Currently Reading
Understanding How Stress Affects Poor Medication Adherence in Type 2 Diabetes
October 23, 2016 – Mary Caffrey
Omnipod Feasibility Study Seeks to Perfect Formulas That Will Make Artificial Pancreas Run
October 21, 2016 – Mary Caffrey
What Teens Weigh Can Predict Future Diabetes Mortality, Study Finds
October 20, 2016 – Mary Caffrey
Bach, Califf Elected to National Academy of Medicine
October 19, 2016 – Mary Caffrey
High-Doses of Antidepressants Less Risky on Heart Than Initially Thought
October 18, 2016 – Jackie Syrop
More Research Needed to Understand Link Between Diabetes, Fractures
October 17, 2016 – AJMC Staff
This Week in Managed Care: October 14, 2016
October 14, 2016
Diabetes, Obesity Linked to Liver Cancer in Study
October 14, 2016 – Mary Caffrey
Nearly Half of Pregnant Women Gained More Weight Than Recommended in 2015
October 13, 2016 – Mary Caffrey

Understanding How Stress Affects Poor Medication Adherence in Type 2 Diabetes

Mary Caffrey
While the link between stress and medication adherence is well known, this study attempted to measure how much stress affected adherence.
Emotional distress has long been recognized as a factor in poor medication adherence in type 2 diabetes (T2D); failing to treat underlying depression is seen as a risk factor in getting patients to stick with a diabetes regimen.

In fact, collaborative care, which addresses a patient’s behavioral health and diabetes care needs within one practice, has gained enough momentum that the proposed 2017 Medicare Physician Fee Schedule calls for letting practices bill for it.

But understanding just how much being depressed affects one’s ability to stick with a medication regimen is harder to gauge. A new study appearing in Diabetes Care sought to examine this by matching patient reports of depression with verifiable measures of adherence.

Researchers studied a diverse group of 104 patients with T2D over 3 months, measuring their medication adherence in 2 ways: first with electronic monitoring and then with self-reports. They also evaluated the patients’ levels of depression in interviews and took blood samples to test glycated hemoglobin (A1C).

Baseline diabetes distress was a significant predictor of adherence based on the electronic monitoring. Over the 3 months, patients’ average adherence was 76.1%, as measured electronically, compared with 83.7% by self-reports. Higher levels of self-reported depression, and that confirmed in interviews, showed a significant bivariate association with electronic (β = −0.29) and self-reported (β = −0.24) nonadherence at follow-up.

The authors found support for the idea that diabetes-related distress and depression are risk factors for nonadherence as their severity increases. Curiously, this effect is driven by the somatic symptoms of depression—the behaviors associated with pain and fatigue—rather than the cognitive problems, such as forgetfulness. The authors said the link merits further investigation.

Reference

Gonzalez JS, Kane NS, Binko DH, Shapira A, Hoogendoorn CJ. Tangled up in blue: unraveling the links between emotional distress and treatment adherence in type 2 diabetes [published October 18, 2016]. Diabetes Care. http://dx.doi.org/10.2337/dc16-1657.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up